Future strategies in acid-peptic disorders: concluding remarks.
Gustavsson
S
S
Department of Surgery, University Hospital, Uppsala, Sweden.
Engstrand
L
L
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002167:Campylobacter / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000150:complications / Q000188:drug therapy; D004415:Dyspepsia / Q000188:drug therapy*; D005544:Forecasting; D005762:Gastroenterology / Q000639:trends*; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D012008:Recurrence
D000900:Anti-Bacterial Agents